Table of Contents United States Pulmonary Drug Delivery Systems Market Report 2018 1 Pulmonary Drug Delivery Systems Overview 1.1 Product Overview and Scope of Pulmonary Drug Delivery Systems 1.2 Classification of Pulmonary Drug Delivery Systems by Product Category 1.2.1 United States Pulmonary Drug Delivery Systems Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Pulmonary Drug Delivery Systems Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Nebulizers 1.2.4 Dry Powder Inhaler (DPI) 1.2.5 Metered Dose Inhaler (MDI) 1.3 United States Pulmonary Drug Delivery Systems Market by Application/End Users 1.3.1 United States Pulmonary Drug Delivery Systems Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 COPD 1.3.3 Asthma 1.3.4 Others 1.4 United States Pulmonary Drug Delivery Systems Market by Region 1.4.1 United States Pulmonary Drug Delivery Systems Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Pulmonary Drug Delivery Systems Status and Prospect (2013-2025) 1.4.3 Southwest Pulmonary Drug Delivery Systems Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Pulmonary Drug Delivery Systems Status and Prospect (2013-2025) 1.4.5 New England Pulmonary Drug Delivery Systems Status and Prospect (2013-2025) 1.4.6 The South Pulmonary Drug Delivery Systems Status and Prospect (2013-2025) 1.4.7 The Midwest Pulmonary Drug Delivery Systems Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Pulmonary Drug Delivery Systems (2013-2025) 1.5.1 United States Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2025) 1.5.2 United States Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2025) 2 United States Pulmonary Drug Delivery Systems Market Competition by Players/Suppliers 2.1 United States Pulmonary Drug Delivery Systems Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Pulmonary Drug Delivery Systems Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Pulmonary Drug Delivery Systems Average Price by Players/Suppliers (2013-2018) 2.4 United States Pulmonary Drug Delivery Systems Market Competitive Situation and Trends 2.4.1 United States Pulmonary Drug Delivery Systems Market Concentration Rate 2.4.2 United States Pulmonary Drug Delivery Systems Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Pulmonary Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Type 3 United States Pulmonary Drug Delivery Systems Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Pulmonary Drug Delivery Systems Sales and Market Share by Region (2013-2018) 3.2 United States Pulmonary Drug Delivery Systems Revenue and Market Share by Region (2013-2018) 3.3 United States Pulmonary Drug Delivery Systems Price by Region (2013-2018) 4 United States Pulmonary Drug Delivery Systems Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Pulmonary Drug Delivery Systems Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2013-2018) 4.3 United States Pulmonary Drug Delivery Systems Price by Type (2013-2018) 4.4 United States Pulmonary Drug Delivery Systems Sales Growth Rate by Type (2013-2018) 5 United States Pulmonary Drug Delivery Systems Sales (Volume) by Application (2013-2018) 5.1 United States Pulmonary Drug Delivery Systems Sales and Market Share by Application (2013-2018) 5.2 United States Pulmonary Drug Delivery Systems Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Pulmonary Drug Delivery Systems Players/Suppliers Profiles and Sales Data 6.1 3M 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 GSK 6.2.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 AstraZeneca 6.3.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Cipla 6.4.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Chiesi 6.5.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Boehringer Ingelheim 6.6.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Aptar 6.7.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Novartis 6.8.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Philips Respironics 6.9.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Omron Healthcare 6.10.2 Pulmonary Drug Delivery Systems Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 PARI 6.12 Skyepharma 6.13 CareFusion 6.14 Shanghai Huarui 6.15 Taian Character 6.16 Chia Tai Tianqing 7 Pulmonary Drug Delivery Systems Manufacturing Cost Analysis 7.1 Pulmonary Drug Delivery Systems Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Systems 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Pulmonary Drug Delivery Systems Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Pulmonary Drug Delivery Systems Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Pulmonary Drug Delivery Systems Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Pulmonary Drug Delivery Systems Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Pulmonary Drug Delivery Systems Sales Volume Forecast by Type (2018-2025) 11.3 United States Pulmonary Drug Delivery Systems Sales Volume Forecast by Application (2018-2025) 11.4 United States Pulmonary Drug Delivery Systems Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Pulmonary Drug Delivery Systems Figure United States Pulmonary Drug Delivery Systems Market Size (M Units) by Type (2013-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume Market Share by Type (Product Category) in 2017 Figure Nebulizers Product Picture Figure Dry Powder Inhaler (DPI) Product Picture Figure Metered Dose Inhaler (MDI) Product Picture Figure United States Pulmonary Drug Delivery Systems Market Size (M Units) by Application (2013-2025) Figure United States Sales Market Share of Pulmonary Drug Delivery Systems by Application in 2017 Figure COPD Examples Table Key Downstream Customer in COPD Figure Asthma Examples Table Key Downstream Customer in Asthma Figure Others Examples Table Key Downstream Customer in Others Figure United States Pulmonary Drug Delivery Systems Market Size (Million USD) by Region (2013-2025) Figure The West Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Pulmonary Drug Delivery Systems Sales (M Units) and Growth Rate (2013-2025) Figure United States Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Pulmonary Drug Delivery Systems Market Major Players Product Sales Volume (M Units) (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales (M Units) of Key Players/Suppliers (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Pulmonary Drug Delivery Systems Sales Share by Players/Suppliers Figure 2017 United States Pulmonary Drug Delivery Systems Sales Share by Players/Suppliers Figure United States Pulmonary Drug Delivery Systems Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Pulmonary Drug Delivery Systems Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Pulmonary Drug Delivery Systems Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Pulmonary Drug Delivery Systems Revenue Share by Players/Suppliers Figure 2017 United States Pulmonary Drug Delivery Systems Revenue Share by Players/Suppliers Table United States Market Pulmonary Drug Delivery Systems Average Price (USD/Unit) of Key Players/Suppliers (2013-2018) Figure United States Market Pulmonary Drug Delivery Systems Average Price (USD/Unit) of Key Players/Suppliers in 2017 Figure United States Pulmonary Drug Delivery Systems Market Share of Top 3 Players/Suppliers Figure United States Pulmonary Drug Delivery Systems Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Pulmonary Drug Delivery Systems Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Pulmonary Drug Delivery Systems Product Category Table United States Pulmonary Drug Delivery Systems Sales (M Units) by Region (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales Share by Region (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Share by Region (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Market Share by Region in 2017 Table United States Pulmonary Drug Delivery Systems Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Pulmonary Drug Delivery Systems Revenue Share by Region (2013-2018) Figure United States Pulmonary Drug Delivery Systems Revenue Market Share by Region (2013-2018) Figure United States Pulmonary Drug Delivery Systems Revenue Market Share by Region in 2017 Table United States Pulmonary Drug Delivery Systems Price (USD/Unit) by Region (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales (M Units) by Type (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales Share by Type (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Share by Type (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Market Share by Type in 2017 Table United States Pulmonary Drug Delivery Systems Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Pulmonary Drug Delivery Systems Revenue Share by Type (2013-2018) Figure Revenue Market Share of Pulmonary Drug Delivery Systems by Type (2013-2018) Figure Revenue Market Share of Pulmonary Drug Delivery Systems by Type in 2017 Table United States Pulmonary Drug Delivery Systems Price (USD/Unit) by Types (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Growth Rate by Type (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales (M Units) by Application (2013-2018) Table United States Pulmonary Drug Delivery Systems Sales Market Share by Application (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Market Share by Application (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Market Share by Application in 2017 Table United States Pulmonary Drug Delivery Systems Sales Growth Rate by Application (2013-2018) Figure United States Pulmonary Drug Delivery Systems Sales Growth Rate by Application (2013-2018) Table 3M Basic Information List Table 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure 3M Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure 3M Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure 3M Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table GSK Basic Information List Table GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure GSK Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure GSK Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure GSK Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table AstraZeneca Basic Information List Table AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure AstraZeneca Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure AstraZeneca Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure AstraZeneca Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Cipla Basic Information List Table Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Cipla Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Cipla Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Cipla Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Chiesi Basic Information List Table Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Chiesi Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Chiesi Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Chiesi Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Boehringer Ingelheim Basic Information List Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Boehringer Ingelheim Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Aptar Basic Information List Table Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Aptar Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Aptar Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Aptar Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Novartis Basic Information List Table Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Novartis Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Novartis Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Novartis Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Philips Respironics Basic Information List Table Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Philips Respironics Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Philips Respironics Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Philips Respironics Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table Omron Healthcare Basic Information List Table Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Omron Healthcare Pulmonary Drug Delivery Systems Sales Growth Rate (2013-2018) Figure Omron Healthcare Pulmonary Drug Delivery Systems Sales Market Share in United States (2013-2018) Figure Omron Healthcare Pulmonary Drug Delivery Systems Revenue Market Share in United States (2013-2018) Table PARI Basic Information List Table Skyepharma Basic Information List Table CareFusion Basic Information List Table Shanghai Huarui Basic Information List Table Taian Character Basic Information List Table Chia Tai Tianqing Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Pulmonary Drug Delivery Systems Figure Manufacturing Process Analysis of Pulmonary Drug Delivery Systems Figure Pulmonary Drug Delivery Systems Industrial Chain Analysis Table Raw Materials Sources of Pulmonary Drug Delivery Systems Major Players/Suppliers in 2017 Table Major Buyers of Pulmonary Drug Delivery Systems Table Distributors/Traders List Figure United States Pulmonary Drug Delivery Systems Sales Volume (M Units) and Growth Rate Forecast (2018-2025) Figure United States Pulmonary Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Pulmonary Drug Delivery Systems Price (USD/Unit) Trend Forecast (2018-2025) Table United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Type (2018-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Type (2018-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Type in 2025 Table United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Application (2018-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Application (2018-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Application in 2025 Table United States Pulmonary Drug Delivery Systems Sales Volume (M Units) Forecast by Region (2018-2025) Table United States Pulmonary Drug Delivery Systems Sales Volume Share Forecast by Region (2018-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume Share Forecast by Region (2018-2025) Figure United States Pulmonary Drug Delivery Systems Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources